Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling

Authors

Jin Qian, Stanford University
Bauer L LeSavage, Stanford University
Kelsea M Hubka, Stanford University
Chenkai Ma, CSIRO Health and Biosecurity
Suchitra Natarajan, Stanford University
Joshua T Eggold, Stanford University
Yiren Xiao, Stanford University
Katherine C Fuh, Washington University School of Medicine in St. Louis
Venkatesh Krishnan, Stanford University
Annika Enejder, Stanford University
Sarah C Heilshorn, Stanford University
Oliver Dorigo, Stanford University
Erinn B Rankin, Stanford University

Journal

The Journal of Clinical Investigation

Publication Date

2021

Volume

131

Issue

16

Document Type

Open Access Publication

DOI

10.1172/JCI146186

Rights and Permissions

Qian J, LeSavage BL, Hubka KM, et al. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. 2021;131(16):e146186. doi:10.1172/JCI146186

Recommended Citation

Qian, Jin; LeSavage, Bauer L; Hubka, Kelsea M; Ma, Chenkai; Natarajan, Suchitra; Eggold, Joshua T; Xiao, Yiren; Fuh, Katherine C; Krishnan, Venkatesh; Enejder, Annika; Heilshorn, Sarah C; Dorigo, Oliver; and Rankin, Erinn B, "Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling." The Journal of Clinical Investigation. 131, 16. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10679